Qinghong L. Yu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Cord blood transfusion added matched unrelated donor transplantation as a preferable choice for aplastic anaemia: a comparative study from a single centre.
Journal: Annals of medicine
Published: March 17, 2026
OLFML2A mediates cell cycle regulation in triple-negative breast cancer via EZH2.
Journal: Frontiers in oncology
Published: November 20, 2025
Comparison of clinical outcomes between early and delayed allogeneic hematopoietic stem cell transplantation for severe aplastic anemia: a single-center retrospective study.
Journal: Annals of hematology
Published: November 12, 2025
Comment on the paper "Effect of duration of hormonal contraceptive use on breast cancer risk: a systematic review and meta-analysis of cohort studies".
Journal: Maturitas
Published: November 06, 2025
Konjac petroleum ether extract inhibits triple-negative breast cancer cell migration and invasion by attenuating OLFML2A-mediated epithelial-mesenchymal transition.
Journal: Frontiers in pharmacology
Published: October 29, 2025
Superior outcomes with the FABT regimen in haploidentical transplantation for aplastic anemia in patients under 40 years old: a single-center retrospective study.
Journal: Clinical and experimental medicine
Published: October 28, 2025
A comparative study of the impact of lineal relatives versus collateral relatives donor on prognosis in haplo-HSCT for aplastic anemia.
Journal: Frontiers in immunology
Published: October 18, 2025
Novel FABT-Based Conditioning Regimen With Haploidentical Transplantation for Severe Aplastic Anemia: A Prospective, Single-Center, Phase II Clinical Trial.
Journal: Transplantation and cellular therapy
Published: October 13, 2025
Clinical Outcomes of Haploidentical Transplantation Combined With Umbilical Cord Blood and Mesenchymal Stem Cells Co-Infusion for Aplastic Anemia: A Single-Center Retrospective Study.
Journal: Transplantation proceedings
Published: September 29, 2025
Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study.
Journal: Frontiers in medicine
Published: September 24, 2025
Plasma exchange combined with anti-B-cell therapy enables comparable outcomes between DSA-positive and DSA-negative aplastic anemia after haplo-HSCT: a propensity-score-matched cohort study.
Journal: Annals of hematology
Published: August 12, 2025
Last Updated: 09/26/2026